Implementing
the Medicare Prescription Drug Benefit and Medicare Advantage Program: Perspectives
on the Proposed Rules
September 14 , 2004, at 10:00 a.m. in 215 Dirksen Senate Office Building
Member Statements:
Charles Grassley, IA
Max Baucus, MT
Witness Statements:
Panel I
Dr. Mark B. McClellan, M.D. Ph.D., Administrator, Centers for Medicare and Medicaid Services, Washington, DC
Panel II
Ms. Karen Ignagni, President and CEO, America's Health Insurance Plans, Washington, DC
Mr. Mark Merritt, President and CEO, Pharmaceutical Care Management Association, Washington, DC
Mr. Michael J. Fitzpatrick, M.S. W., Executive Director, National Alliance for the Mentally Ill, Arlington, VA
Mr. Gerald Shea, Assistant to the President for Government Affairs, AFL-CIO, Washington, DC
Mr. Larry Burton, Executive Director, Business Roundtable, Washington, DC
